Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 1732638, 6 pages
https://doi.org/10.1155/2017/1732638
Research Article

Hip Osteonecrosis Is Associated with Increased Plasma IL-33 Level

1Department of Bone and Joint Surgery, Peking University China-Japan Friendship School of Clinical Medicine, Beijing 100029, China
2Department of Bone and Joint Surgery, Center for Osteonecrosis and Joint Preserving & Reconstruction, China-Japan Friendship Hospital, Beijing 100029, China
3Department of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China

Correspondence should be addressed to Bailiang Wang; moc.621@cideapohtro_gnaw

Received 25 October 2016; Accepted 25 December 2016; Published 11 January 2017

Academic Editor: Qingdong Guan

Copyright © 2017 Jinhui Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Zhao, M. Yu, K. Hu et al., “Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey,” Chinese Medical Journal, vol. 128, no. 21, pp. 2843–2850, 2015. View at Publisher · View at Google Scholar
  2. K. Ohzono, M. Saito, K. Takaoka et al., “Natural history of nontraumatic avascular necrosis of the femoral head,” Journal of Bone and Joint Surgery - Series B, vol. 73, no. 1, pp. 68–72, 1991. View at Google Scholar · View at Scopus
  3. C.-J. Wang, F.-S. Wang, J.-Y. Ko et al., “Extracorporeal shockwave therapy shows regeneration in hip necrosis,” Rheumatology, vol. 47, no. 4, pp. 542–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Assouline-Dayan, C. Chang, A. Greenspan, Y. Shoenfeld, and M. E. Gershwin, “Pathogenesis and natural history of osteonecrosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 2, pp. 94–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Boss and I. Misselevich, “Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals,” Veterinary Pathology, vol. 40, no. 4, pp. 345–354, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Okazaki, Y. Nishitani, S. Nagoya, M. Kaya, T. Yamashita, and H. Matsumoto, “Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway,” Rheumatology, vol. 48, no. 3, pp. 227–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. K. W. Kim, “Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease,” Journal of Bone and Joint Surgery - Series A, vol. 94, no. 7, pp. 659–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. K. W. Kim and P.-H. Su, “Development of flattening and apparent fragmentation following ischemic necrosis of the capital femoral epiphysis in a piglet model,” Journal of Bone and Joint Surgery A, vol. 84, no. 8, pp. 1329–1334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K. W. Frommer, E. Neumann, and U. Lange, “Inflammation and bone: osteoimmunological aspects,” Zeitschrift fur Rheumatologie, vol. 75, no. 5, pp. 444–450, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Samara, P. Kollia, Z. Dailiana et al., “Predictive role of cytokine gene polymorphisms for the development of femoral head osteonecrosis,” Disease Markers, vol. 33, no. 4, pp. 215–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Schmitz, A. Owyang, E. Oldham et al., “IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines,” Immunity, vol. 23, no. 5, pp. 479–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Carriere, L. Roussel, N. Ortega et al., “IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 282–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Saidi, F. Bouri, P. Lencel et al., “IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling,” Cytokine, vol. 53, no. 3, pp. 347–354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Schulze, T. Bickert, F. T. Beil et al., “Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells,” Journal of Bone and Mineral Research, vol. 26, no. 4, pp. 704–717, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Saleh, D. Eeles, J. M. Hodge et al., “Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro,” Endocrinology, vol. 152, no. 5, pp. 1911–1922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. J. Nile, E. Barksby, P. Jitprasertwong, P. M. Preshaw, and J. J. Taylor, “Expression and regulation of interleukin-33 in human monocytes,” Immunology, vol. 130, no. 2, pp. 172–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Kakkar and R. T. Lee, “The IL-33/ST-2 pathway: therapeutic target and novel biomarker,” Nature Reviews Drug Discovery, vol. 7, no. 10, pp. 827–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Saidi and D. Magne, “Interleukin-33: a novel player in osteonecrosis of the femoral head?” Joint Bone Spine, vol. 78, no. 6, pp. 550–554, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. W. H. Harris, “Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty,” The Journal of Bone and Joint Surgery. American Volume, vol. 51, no. 4, pp. 737–755, 1969. View at Publisher · View at Google Scholar
  20. Z. R. Li, Z. H. Liu, W. Sun et al., “The classification of osteonecrosis of the femoral head based on the three pillars structure: China-Japan Friendship Hospital (CJFH) classification,” Chinese Journal of Orthopaedics, vol. 32, no. 6, pp. 515–520, 2012. View at Google Scholar
  21. J. W. M. Gardeniers, “ARCO committee on terminology and staging (report from the Nijmegen meeting),” ARCO News Letter, vol. 3, pp. 153–159, 1991. View at Google Scholar
  22. W. Sun, Z.-R. Li, B.-L. Wang, B.-L. Liu, Q.-D. Zhang, and W.-S. Guo, “Relationship between preservation of the lateral pillar and collapse of the femoral head in patients with osteonecrosis,” Orthopedics, vol. 37, no. 1, pp. e24–e28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Herring, H. T. Kim, and R. Browne, “Legg-Calvé-Perthes disease. Part I: classification of radiographs with use of the modified lateral pillar and stulberg classifications,” Journal of Bone and Joint Surgery A, vol. 86, no. 10, pp. 2103–2120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Wu, W. Xu, X. Feng et al., “TNF-a mediated inflammatory macrophage polarization contributes to the pathogenesis of steroid-induced osteonecrosis in mice,” International Journal of Immunopathology and Pharmacology, vol. 28, no. 3, pp. 351–361, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Mun, N. Y. Ko, H. S. Kim et al., “Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes,” Cellular and Molecular Life Sciences, vol. 67, no. 22, pp. 3883–3892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-S. Choi, H.-J. Choi, J.-K. Min et al., “Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production,” Blood, vol. 114, no. 14, pp. 3117–3126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Zuo, W. Sun, D. Zhao, F. Gao, Y. Su, and Z. Li, “Investigating clinical failure of bone grafting through a window at the femoral head neck junction surgery for the treatment of osteonecrosis of the femoral head,” PLoS ONE, vol. 11, no. 6, Article ID 0156903, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Tian, Q. Wen, X. Dang, W. You, L. Fan, and K. Wang, “Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis,” BMC Musculoskeletal Disorders, vol. 15, no. 1, article 18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. S. Weinstein, R. L. Jilka, A. Michael Parfitt, and S. C. Manolagas, “Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone,” Journal of Clinical Investigation, vol. 102, no. 2, pp. 274–282, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Weinstein, R. W. Nicholas, and S. C. Manolagas, “Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 8, pp. 2907–2912, 2000. View at Publisher · View at Google Scholar · View at Scopus